Abstract:The gut taxonomical profile is one of the contributory factors in maintaining homeostasis within the central nervous system (CNS). Of late, the efficacy of diet as a target of treatment, and how various dietary interventions may modulate gut microbiota differently have been an area of focus in research. The role of ketogenic diet (KD) in particular has been well-established in other diseases like intractable epilepsy due to its postulated effects on gut microbiome modulation, resulting in neuronal stability and prevention of epileptogenesis. Therefore, this systematic review aimed to critically evaluate the current available literature investigating the interplay between the three distinct entities: ketogenic diet, neurodegeneration, and gut microbiota, which may serve as a focus guide for future neurodegenerative diseases (ND) therapeutic research. A comprehensive literature search was performed on three databases; PubMed, Scopus, and Ovid Medline. A total of 12 articles were selected for critical appraisal, after subjecting to the inclusion and exclusion criteria in this study. The selected articles revealed that the hopes of KD as a treatment modality for ND are being ventured into as these individuals are said to acquire gut dysbiosis, primarily through increased colonization of phyla Proteobacteria and Firmicutes . Although positive effects including restoration of healthy gut microbes such as Akkermansia Muciphilia sp., improvement in cognitive functioning and decline in neuro-inflammatory markers were noted, this systematic review also depicted conflicting results such as decrease in alpha and beta species diversity as well as diminution of healthy gut commensals such as Bifidobacteriace . In addition, positive neuromodulation were also observed, notably an increase in cerebral blood perfusion to ventromedial hippocampal region via increased expression of eNOS and clearance of amyloid-beta proteins across the blood-brain-barrier via expression of p-glycoprotein. Neuroprotective mechanisms of ketogenic diet also included downregulation of mTOR expression, to prevention acceleration of pathological diseases such as Alzheimer's. Thus due to this conflicting/contrasting results demonstrated by ketogenic diet, such as a decline in gut species richness, diminution in beneficial microbes and decline cognition unless delivered in an intermittent fasting pattern, further studies may still be required before prior recommendation of a ketogenic diet therapeutic regime in ND patients.

A Transcriptomic View

Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders

Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia

Metabolomic Analysis Reveals Metabolic Disturbance in the Cortex and Hippocampus of Subchronic Mk-801 Treated Rats

Welfare and productivity of restricted broiler breeder females fed ad libitum or restricted after the peak of egg production.

MEASUREMENTS OF INPLANE POLARIZATION TRANSFER COEFFICIENT IN 24Mg(p,p') REACTION AT Ep=65 MeV

Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

Ketone Bodies and Inflammation Modulation: A Mini-Review on Ketogenic Diet's Potential Mechanisms in Mood Disorders

Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence

The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients

Potential Benefits of Ketone Therapy as a Novel Immunometabolic Treatment for Schizophrenia

[Findings after the infection of silicone oil into the rabbit vitreous body and electron microscopic study of the retina].

A system biology approach based on metabolic biomarkers and protein–protein interactions for identifying pathways underlying schizophrenia and bipolar disorder

Ketogenic diets in clinical psychology: examining the evidence and implications for practice

A Pilot Study of a Ketogenic Diet in Bipolar Disorder: Clinical, Metabolomic and Magnetic Resonance Spectroscopy Outcomes

Retrospective case study: ketogenic metabolic therapy in the effective management of treatment-resistant depressive symptoms in bipolar disorder

[Effect of Solcoseryl on cellular growth].

A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140/90mmHg.

Hypometabolism in Autism Spectrum Disorder: Insights from Brain and Blood Transcriptomics

Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders

Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: A molecular crosstalk